Vyloy With Chemotherapy Approved for Gastric or Gastroesophageal Junction Adenocarcinoma

The FDA has approved zolbetuximab-clzb (Vyloy, Astellas Pharma), a claudin 18.2 (CLDN18.2)-directed cytolytic ...

OCTOBER 21, 2024